2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) affects the thyroid morphologically and/or functionally in adult animals. Recently, the National Toxicology Program conducted a 2-year gavage study of TCDD in female Harlan Sprague—Dawley rats. The only treatment-related alterations found in thyroid follicles were decreased luminal size and increased height of the follicular epithelial cells, without prominent protrusion into the lumen. The present study elucidated the nature of these follicular lesions. Thyroid glands of 10 rats each from the control, high (100 ng/kg/day)-dose, and stop-study (100 ng/kg/day, 30 weeks; vehicle to study termination) groups in the 2-year study were evaluated microscopically. Twenty randomly selected follicles were measured morphometrically in each animal. TCDD treatment significantly decreased the mean ratio of luminal/epithelial areas and increased the mean sectional epithelial height of the high-dose group compared to controls. Thyroid sections were immunostained with antibody against minichromosome maintenance (MCM) proteins, a novel cell-cycle biomarker. The MCM labeling index of the high-dose group was significantly higher than that of the control; however, the TUNEL labeling index was also higher in the high-dose group than the control. All data from the stop group were comparable to those from controls. These results indicate that the follicular cell response was hypertrophic and reversible. This information should contribute to diagnosis of nonneoplastic thyroid follicular lesions in rats.
Ahlborg, U.G., A. Brouwer, M.A. Fingerhut, J.L. Jacobson, S.W. Jacobson, S.W. Kennedy, A.A. Kettrup, J.H. Koeman, H. Poiger, C. Rappe, S.H. Safe, R.F. Seegal, J. Tuomisto, J., and H. van den Berg (1992). “Impact of Polychlorinated Dibenzo-p-dioxins, Dibenzofurans, and Biphenyls on Human and Environmental Health, with Special Emphasis on Application of the Toxic Equivalency Factor Concept.” Eur J Pharmacol228: 179—99.
2.
Alison, M.R., T. Hunt, and S.J. Forbes (2002). “Minichromosome Maintenance (MCM) Proteins May be Pre-Cancer Markers.” Gut50: 290—1.
3.
Barnes, D.G. (1991). “Toxicity Equivalents and EPA's Risk Assessment of 2,3,7,8-TCDD.” Sci Total Environ104: 73—86.
4.
Becher, H., D. Flesch-Janys, T. Kauppinen, M. Kogevinas, K. Steindorf, A. Manz, and J. Wahrendorf (1996). “Cancer Mortality in German Male Workers Exposed to Phenoxy Herbicides and Dioxins.” Cancer Causes Control7: 312—21.
5.
Bock, K.W., H. Gschaidmeier, H. Heel, T. Lehmkoster,P.A. Munzel, F. Raschko, and B. Bock-Hennig (1998). “Ah Receptor-Controlled Transcriptional Regulation and Function of Rat and Human UDP-Glucuronosyltransferase Isoforms .” Adv Enzyme Regul38: 207—22.
6.
Bruemmer, D., F. Yin, J. Liu, J.P. Berger, T. Kiyono, J. Chen, E. Fleck, A.J. Van Herle, B.M. Forman, and R.E. Law (2003a). “Peroxisome Proliferatoractivated Receptor gamma Inhibits Expression of Minichromosome Maintenance Proteins in Vascular Smooth Muscle Cells.” Mol Endocrinol17: 1005—18.
7.
Bruemmer, D., F. Yin, J. Liu, T. Kiyono, E. Fleck, A. Van Herle, K. Graf, and R.E. Law (2003b). “Atorvastatin Inhibits Expression of Minichromosome Maintenance Proteins in Vascular Smooth Muscle Cells.” Eur J Pharmacol462: 15—23.
8.
Capen, C.C. (2001). “Overview of Structural and Functional Lesions in Endocrine Organs of Animals.” Toxicol Pathol29: 8—33.
9.
Capen, C.C., R.A. DeLellis, and J.T. Yarrington (2001). “Endocrine system. Handbook of Toxicologic Pathology.” W. M. Haschek, C. G. Rousseaux and M. A. Wallig. Vol. 2. Academic Press, San Diego, CA.
10.
Chong, J.P., H.M. Mahbubani, C.Y. Khoo, and J.J. Blow (1995). “Purification of an MCM-Containing Complex as a Component of the DNA Replication Licensing System.” Nature375: 418—21.
11.
Della Porta, G., T.A. Dragani, and G. Sozzi (1987). “Carcinogenic Effects of Infantile and Long-Term 2,3,7,8-tetrachlorodibenzo-p-dioxin Treatment in the Mouse.” Tumori73: 99—107.
12.
Fahrig, R. (1993). “Genetic Effects of Dioxins in the Spot Test with Mice.” Environ Health Perspect101 (Suppl 3): 257—61.
13.
Fingerhut, M.A., W.E. Halperin, D.A. Marlow, L.A. Piacitelli, P.A. Honchar, M.H. Sweeney, A.L. Greife, P.A. Dill, K. Steenland, and A.J. Suruda (1991). “Cancer Mortality in Workers Exposed to 2,3,7,8tetrachlorodibenzo-p-dioxin.” N Engl J Med324: 212—8.
14.
Freeman, A., L.S. Morris, A.D. Mills, K. Stoeber, R.A. Laskey, G.H. Williams, and N. Coleman (1999). “Minichromosome Maintenance Proteins as Biological Markers of Dysplasia and Malignancy.” Clin Cancer Res5: 2121— 32.
15.
Gao, X., P.F. Terranova, and K.K. Rozman (2000). “Effects of Polychlorinated Dibenzofurans, Biphenyls, and Their Mixture with dibenzo-p-dioxins on Ovulation in the Gonadotropin-Primed Immature Rat: Support for the Toxic Equivalency Concept.” Toxicol Appl Pharmacol163: 115—24.
16.
Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson (1992). “Identification of Programmed Cell Death In Situ Via Specific Labeling of Nuclear DNA Fragmentation .” J Cell Biol119: 493—501.
17.
Geiger, L.E. and R.A. Neal (1981). “Mutagenicity Testing of 2,3,7,8-tetrachlordibenzo-p-dioxin in Histidine Auxotrophs of Salmonella typhimurium.” Toxicol Appl Pharmacol59: 125—9.
18.
Gorski, J.R. and K. Rozman (1987). “Dose-response and Time Course of Hypothyroxinemia and Hypoinsulinemia and Characterization of Insulin Hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated Rats.” Toxicology44: 297—307.
19.
Haag-Grönlund, M., N. Johansson, R. Fransson-Steen, H. Håkansson, G. Scheu, and L. Wärngård (1998). “Interactive Effects of Three Structurally Different Polychlorinated Biphenyls in a Rat Liver Tumor Promotion Bioassay .” Toxicol Appl Pharmacol152: 153—65.
20.
Hardisty, J.F. and G.A. Boorman (1990). Thyroid gland. Pathology of the Fischer Rat. Reference and Atlas. G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, Jr., and W. F. MacKenzie. Academic Press, San Diego, CA.
21.
Hardisty, J.F. and G.A. Boorman (1999). Thyroid and parathyroid glands. Pathology of the Mouse. Reference and Atlas. R. R. Maronpot. Cache River Press, Vienna, IL.
22.
Henry, E.C. and T.A. Gasiewicz (1987). “Changes in Thyroid Hormones and Thyroxine Glucuronidation in Hamsters Compared with Rats Following Treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin .” Toxicol Appl Pharmacol89: 165—74.
23.
International Agency for Research on Cancer ( 1997). Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 69. IARC Scientific Publications, Lyon, France.
24.
Kociba, R.J., D.G. Keyes, J.E. Beyer, R.M. Carreon, C.E. Wade, D.A. Dittenber, R.P. Kalnins, L.E. Frauson, C.N. Park, S.D. Barnard, R.A. Hummel, and C.G. Humiston (1978). “Results of a Two-Year Chronic Toxicity and Oncogenicity Study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Rats.” Toxicol Appl Pharmacol46: 279—303.
25.
Kodani, I., K. Shomori, M. Osaki, I. Kuratate, K. Ryoke, and H. Ito (2001). “Expression of Minichromosome Maintenance 2 (MCM2), Ki-67, and Cell-Cycle-Related Molecules, and Apoptosis in the Normal-Dysplasia-Carcinoma Sequence of the Oral Mucosa.” Pathobiology69: 150—8.
26.
Kohn, M.C. (2000). “Effects of TCDD on Thyroid Hormone Homeostasis in the Rat.” Drug Chem Toxicol23: 259—77.
27.
Kohn, M.C., C.H. Sewall, G.W. Lucier, and C.J. Portier (1996). “A Mechanistic Model of Effects of Dioxin on Thyroid Hormones in the Rat.” Toxicol Appl Pharmacol136: 29—48.
28.
Kubota, Y., S. Mimura, S. Nishimoto, H. Takisawa, and H. Nojima (1995). “Identification of the Yeast MCM3-Related Protein as a Component of Xenopus DNA Replication Licensing Factor. ” Cell81: 601—9.
29.
Madine, M.A., C.Y. Khoo, A.D. Mills, and R.A. Laskey (1995). “MCM3 Complex Required for Cell Cycle Regulation of DNA Replication in Vertebrate Cells.” Nature375: 421—4.
30.
Miller, R.G. (1966). Simultaneous Statistical Inference. McGraw-Hill, New York.
31.
National Toxicology Program (1982a). Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS No. 1746-01-6) in Osborne-Mendel Rats and B6C3F1 Mice (Gavage Study). NTP TR 209, NIH Publication No. 82-1765. National Toxicology Program , Research Triangle Park, NC.
32.
National Toxicology Program (1982b). Carcinogenesis Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS No. 1746-01-6) in Swiss-Webster Mice (Dermal Study). NTP TR 201, NIH Publication No. 82-1757. National Toxicology Program, Research Triangle Park, NC.
33.
National Toxicology Program (2003). Toxicology and Carcinogenesis Studies of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS No. 1746-01-6) in Female Harlan Sprague—Dawley Rats (Gavage Studies) . National Toxicology Program, Research Triangle Park, NC (in preparation).
34.
Nishimura, N., Y. Miyabara, M. Sato, J. Yonemoto, and C. Tohyama (2002). “Immunohistochemical Localization of Thyroid Stimulating Hormone Induced by a Low Oral Dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Female Sprague—Dawley Rats.” Toxicology171: 73—82.
35.
Ott, M.G. and A. Zober (1996). “Cause Specific Mortality and Cancer Incidence among Employees Exposed to 2,3,7,8-TCDD after a 1953 Reactor Accident.” Occup Environ Med53: 606—12.
36.
Potter, C.L., I.G. Sipes, and D.H. Russell (1983). “Hypothyroxinemia and Hypothermia in Rats in Response to 2,3,7,8-tetrachlorodibenzo-p-dioxin Administration.” Toxicol Appl Pharmacol69: 89—95.
37.
Rao, M.S., V. Subbarao, J.D. Prasad, and D.G. Scarpelli (1988). “Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Syrian Golden Hamster.” Carcinogenesis9: 1677—9.
38.
Rodins, K., M. Cheale, N. Coleman, and S.B. Fox (2002). “Minichromosome Maintenance Protein 2 Expression in Normal Kidney and Renal Cell Carcinomas: Relationship to Tumor Dormancy and Potential Clinical Utility.” Clin Cancer Res8: 1075—81.
39.
Saracci, R., M. Kogevinas, P.A. Bertazzi, B. H. Bueno de Mesquita, D. Coggon, L.M. Green, T. Kauppinen, K.A. L'Abbe, M. Littorin, E. Lynge, J.D. Mathews, M. Neuberger, J. Osman, N. Pearce, and R. Winkelmann (1991). “Cancer Mortality in Workers Exposed to Chlorophenoxy Herbicides and Chlorophenols.” Lancet338: 1027—32.
40.
Schuur, A.G., F.M. Boekhorst, A. Brouwer, and T.J. Visser (1997). “Extrathyroidal Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on Thyroid Hormone Turnover in Male Sprague—Dawley Rats.” Endocrinology138: 3727—34.
41.
Sewall, C.H., N. Flagler, J.P. Vanden Heuvel, G.C. Clark, A.M. Tritscher, R.R. Maronpot, and G.W. Lucier (1995). “Alterations in Thyroid Function in Female Sprague—Dawley Rats Following Chronic Treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin .” Toxicol Appl Pharmacol132: 237—44.
42.
Shimo, T., K. Mitsumori, H. Onodera, K. Yasuhara, M. Takahashi, Y. Ueno, and Y. Hayashi (1994). “Time Course Observation of Thyroid Proliferative Lesions and Serum TSH Levels in Rats Treated with Thiourea after DHPN Initiation .” Cancer Lett85: 141—9.
43.
Takizawa, T., K. Mitsumori, T. Tamura, M. Nasu, M. Ueda, T. Imai, and M. Hirose (2003). “Hepatocellular Tumor Induction in Heterozygous p53-Deficient CBA Mice by a 26-Week Dietary Administration of Kojic Acid. ” Toxicol Sci73: 287—93.
44.
van Birgelen, A.P., E.A. Smit, I.M. Kampen, C.N. Groeneveld, K.M. Fase, J. Van der Kolk, H. Poiger, M. Van den Berg, J.H. Koeman, and A. Brouwer (1995). “Subchronic Effects of 2,3,7,8-TCDD or PCBs on Thyroid Hormone Metabolism: Use in Risk Assessment.” Eur J Pharmacol293: 77—85.
45.
van der Plas, S.A., I. Lutkeschipholt, B. Spenkelink, and A. Brouwer (2001). “Effects of Subchronic Exposure to Complex Mixtures of Dioxin-Like and Non-dioxin-like Polyhalogenated Aromatic Compounds on Thyroid Hormone and Vitamin A Levels in Female Sprague—Dawley Rats .” Toxicol Sci59: 92—100.
46.
van der Plas, S.A., H. Sundberg, H. van den Berg, G. Scheu, P. Wester, S. Jensen, A. Bergman, J. de Boer, J.H. Koeman, and A. Brouwer (2000). “Contribution of Planar (0-1 ortho) and Nonplanar (2-4 ortho) Fractions of Aroclor 1260 to the Induction of Altered Hepatic Foci in Female Sprague— Dawley Rats.” Toxicol Appl Pharmacol169: 255—68.
47.
Wharton, S.B., K.K. Chan, J.R. Anderson, K. Stoeber, and G.H. Williams (2001). “Replicative Mcm2 Protein as a Novel Proliferation Marker in Oligodendrogliomas and its Relationship to Ki67 Labelling Index, Histological Grade and Prognosis.” Neuropathol Appl Neurobiol27: 305—13.
48.
Wynford-Thomas, D., B.M. Stringer, and E.D. Williams (1982). “Desensitisation of Rat Thyroid to the Growth-Stimulating Action of TSH During Prolonged Goitrogen Administration; Persistence of Refractoriness Following Withdrawal of Stimulation.”Acta Endocrinol (Copenh)101: 562—9.
49.
Yueh, M.F., Y.H. Huang, A. Hiller, S. Chen, N. Nguyen, and R.H. Tukey, (2003). “Involvement of the Xenobiotic Response Element (XRE) in Ah Receptor-Mediated Induction of Human UDP-Glucuronosyltransferase 1A1.” J Biol Chem278: 15001—6.
